Selection of blockbuster announcements

1、$China Merchants Bank (03968.HK) $Wang Liang was appointed president

China Merchants Bank (03968) announced that the board of directors held the 40th meeting of the eleventh session of the board of directors on May 19, 2022, examined and passed the "motion on the appointment of Mr. Wang Liang as president of China Merchants Bank" and agreed to appoint Wang Liang as president of China Merchants Bank. The term of office is from the date on which the Bank of China Ltd. Insurance Regulatory Commission approves his qualification as president until the expiration of the eleventh board of directors.

2、$XIAOMI Group-W (01810.HK) $The revenue of Q1 was 73.352 billion yuan, down 4.6% from the same period last year.

XIAOMI Group (01810) released Q1 performance report for 2022: Q1 revenue was 73.352 billion yuan (RMB, the same below), down 4.6% from the same period last year. Adjusted net profit of Tencent Q1 was 2.859 billion yuan, down 52.9% from the same period last year. Ting Q1 gross profit was 12.71 billion yuan, down 10.2% from a year earlier. From a business point of view, Q1 smartphone income is 45.763 billion yuan; IoT and consumer products income is 19.477 billion yuan; Internet service income is 7.113 billion yuan.

3、$Mega Ophthalmology-B (06622.HK) $The first patient in the NVK002 Phase III bridging clinical trial (mini-CHAMP) in China was enrolled.

Mega Ophthalmology-B (06622) announced that the first patient in the one-year Phase III bridging clinical trial ("mini CHAMP") of NVK002, one of the company's core products, was enrolled on May 13, 2022. Earlier, in March 2022, the company announced that the first patient was enrolled in a two-year phase III clinical trial ("China CHAMP"). As of May 16, 2022, China CHAMP had successfully enrolled 144 patients, and recruitment was still under way.

4、$Zhengtong Motor (01728.HK) $Shanghai Automobile Group 1.607 billion yuan Jingde Company holds 1.52 billion unlisted foreign capital shares of Dongzheng Finance, which resumed trading today.

Zhengtong Motor (01728) announced that according to the auction details page of Jingdong's judicial auction network platform, the equity auction ended at 10:00 on May 19, 2022. Shanghai Automobile Group Co., Ltd. ("buyer") successfully acquired 1.52 billion unlisted foreign capital shares of Dongzheng Finance held by the company at a transaction price of 1.607 billion yuan.

5、$Smoore International Holdings Limited (06969.HK) $A total of 11.975 million share options were granted

Smoore International Holdings Limited (06969) announced that on 19 May 2022, the Company granted a total of 11.975 million share options to specific eligible employees of the Group under the Post-IPO share option Scheme adopted on 15 June 2020. A total of 11.975 million share options were granted, with a closing price of HK $16.80 per share as at the date of grant.

6、$Propranolol-B (02185.HK) $Carry out RADIUS-HTN test in EUROPCR

Propranolol-B (02185) announced that at EuroPCR 2022 (the official annual meeting of the European Association of Percutaneous Cardiovascular Interventional Therapy), the company and clinical trial researchers finalised a plan for an European clinical trial (the "RADIUS-HTN trial") involving renal artery sympathetic denervation via the radial approach for uncontrolled hypertension (RADIUS-HTN). The European Cardiovascular Research Centre ("CERC") will conduct the RADIUS-HTN trial and evaluate the company's second-generation Iberis ®renal nerve block (RDN) system in patients with uncontrolled hypertension. The RADIUS-HTN trial will compare the efficacy of renal nerve occlusion via transradial approach (TRA) and transarterial approach (TFA). The principal researcher of the RADIUS-HTN trial is Professor FelixMahfoud, a Bachelor of Medicine from Saarland University Hospital Homburg/Saar, and chairman of the working Group on Arterial Hypertension of the German Cardiology Association.

7、$Weichai Power (02338.HK) $It is proposed to buy back A shares of no more than 1.533 billion yuan, and the price does not exceed 17.57 yuan per share.

Weichai Power (02338) announced that the company intends to use its own funds to buy back part of the company's A-share public shares for later implementation of the equity incentive plan. The price of the A-share buyback is not more than RMB 17.57 per share (inclusive). The number of A-share repurchases is expected to be no less than 0.5% of the company's total share capital and not more than 1% of the total share capital, that is, no less than 43632784 shares (inclusive) and no more than 87265568 shares (inclusive). According to the maximum repurchase number of 87265568 shares (inclusive) and the repurchase price ceiling of 17.57 yuan per share (inclusive), the total amount of repurchase funds is expected to not exceed 1.533 billion yuan.

8、$rare Beauty Resources (09936.HK) $It is proposed to issue 60 million new shares to Ganfeng Lithium

Thin Mei Resources (09936) announced that on 19 May 2022, the Company, the subscribers (an indirect wholly-owned subsidiary of Ganfeng Lithium) and China Galaxy entered into a framework subscription agreement under which the subscribers intend to subscribe and the company intends to allot and issue 60 million new shares at the proposed subscription price of HK $4.00 per proposed subscription share.

Important matters

CANSINOBIO-B (06185): Keweisha was included in the World Health Organization emergency use list

Fosun Pharma USA, the holding subsidiary of Shanghai Fosun Pharmaceutical (02196), is authorized exclusively by VerImmune to develop, import and commercialize the tumor immune drug VERI-101 in China.

Li's Big Pharmaceutical Factory (00950): NATULAN obtains Drug Registration license

Fu Hong Hanlin (02696): phase 3 international multicenter clinical study of Hans-like ®combined with chemotherapy and radiotherapy for limited small cell lung cancer completed the first patient administration in China.

Shanghai Fosun Pharmaceutical (02196): holding subsidiary signs license agreement for tumor immune drug VERI-101

Financial data

XIAOMI Group-W (01810): Q1 revenue of 73.352 billion yuan, down 4.6% from the same period last year

Same trip (00780): adjusted EBITDA increased 4.4% to 438 million yuan in the first quarter compared with the same period last year

Parkson Group (03368): the company owner should share the loss of 30.1 million yuan in the first quarter.

GDS Holdings Limited-SW (09698) first quarter net income was 2.243 billion yuan, an increase of 31.5% over the same period last year.

Increase and decrease holdings

Chizi City Science and Technology (09911) won Chairman Liu Chunhe to increase its stake in 100000 shares.

Merger and acquisition and sale

Pattern year Holdings (01777) plans to sell residential property development projects in Yuecheng District, Shaoxing, Zhejiang Province for 760 million yuan.

Shengjie Enterprise (06090) plans to acquire properties around Nottingham University in the UK with HK $102 million.

JD Logistics, Inc. (02618) plans to sell 100% equity in JD.com International Financial Lease for US $30 million.

COSCO Haifa (02866) plans to transfer 10% of the shares of COSCO Shipping Group Finance Company at 910 million yuan and increase its capital by about 1.807 billion yuan.

COSCO Shipping Holdings (01919) intends to acquire the financial stake in COSCO Shipping Group, and the financial registered capital of COSCO Shipping Group will be increased to 19.5 billion yuan.

Investment and operation

Xinjiang Goldwind Science & Technology (02208) intends to apply for filing and list a debt financing plan of no more than 500 million yuan in Beijing Gold Institute.

National United Resources (00254) is committed to exploring the development of freight and logistics industries.

Repurchase cancellation

AIA Group Limited (01299) spent HK $162 million to buy back 2.1 million shares on May 19th.

JD Health (06618) spent HK $30.375 million to buy back 655700 shares on May 19th.

Semiconductor Manufacturing International Corporation (00981) spent HK $66.566 million to buy back 4.215 million shares on May 19th.

Tigermed (03347) spent 29.5815 million yuan to buy back 349400 A shares on May 19th.

Sinotrans (00598) spent 10.2254 million yuan to buy back 2.6947 million A shares on May 19th.

ESR Cayman Limited (01821) spent HK $21.56 million to buy back 963000 shares on May 19th.

Haier Smart Home (06690) spent 82.93 million yuan to buy back 3.29 million A shares on May 19th.

Ketong Core City (00400) spent HK $2.604 million to buy back 1.2 million shares on May 19th.

HSBC Holdings PLC (00005) spent 7.26 million pounds to buy back 1.46 million shares on May 18.

Standard Chartered PLC (02888) spent 6.9996 million pounds to buy back 1.1823 million shares on May 18.

Guotai Junan International (01788) spent HK $2.1865 million to buy back 2.583 million shares on May 19th

Equity incentive

China Life Group (08296) granted a total of 26 million share options

Sino Biopharmaceutical (01177): the trustee further purchased 9 million shares

Li Ning Co. Ltd. (02331) issues 300000 shares under the share option Scheme

Additional rights issue

Fengsheng Holdings (00607) intends to place no more than 2.956 billion shares at an 8.26% discount, raising a maximum of HK $296 million.

Bond bill

Yuexiu Real Estate (00123): Guangzhou Urban Construction plans to issue corporate bonds of no more than 2.15 billion yuan.

Longfor Group (00960): subsidiary issuance of corporate bonds not exceeding 500 million yuan

JD Logistics, Inc. (02618): sell 100% equity of JD.com International Financial Lease to JD.com Technology for 203 million yuan